StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Trading Down 3.8 % AEZS stock opened at $2.01 on Tuesday. The firm has a market cap of $9.76 million, a […]